Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday

Comments
Loading...

With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects American Shared Hospital Services AMS to report quarterly earnings at 1 cent per share on revenue of $7.70 million before the opening bell, according to data from Benzinga Pro. American Shared Hospital Services shares rose 0.3% to $2.97 in after-hours trading.
  • Guess? Inc. GES reported upbeat results for its fourth quarter and named Alberto Toni as CFO. The company said it sees FY26 revenue to increase 3.9% – 6.2% in US Dollars and adjusted EPS of $1.32 – $1.76. Guess shares fell 2.4% to $9.80 in the after-hours trading session.
  • NeuroOne Medical Technologies Corp. NMTC disclosed a common stock public offering. NeuroOne Medical shares dipped 36.1% to $0.5499 in the after-hours trading session.

Check out our premarket coverage here

  • Simulations Plus Inc. SLP posted stronger-than-expected results for its second quarter and issued upbeat FY25 earnings forecast. Simulations Plus shares gained 2.5% to $24.41 in the after-hours trading session.
  • Sangamo Therapeutics Inc. SGMO announced a new agreement with pharmaceutical giant Eli Lilly And Co LLY, granting the company a worldwide exclusive license to leverage the company's novel proprietary neurotropic adeno-associated virus (AAV) capsid, STAC-BBB. Sangamo Therapeutics shares jumped 47.7% to $0.9193 in after-hours trading.

Check This Out:

Photo via Shutterstock

AMS Logo
AMSAmerican Shared Hospital Services
$2.65-%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
35.16
Growth
92.61
Quality
-
Value
84.33
Price Trend
Short
Medium
Long
Got Questions? Ask
Which stocks might benefit from AMS earnings?
How will Guess's revenue outlook impact its stock?
What factors are driving NeuroOne's stock decline?
Can Simulations Plus sustain its growth trajectory?
What market response can we expect from Sangamo Therapeutics after its deal with Eli Lilly?
Which healthcare stocks could rise due to new partnerships?
How could retail trends affect the performance of Guess?
What are the implications of public offerings for investor sentiment?
Are there hidden opportunities in biotech stocks post-Sangamo's news?
Which pharmaceutical firms could be influenced by AAV technology advancements?
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: